Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia.

Javanmard D, Namaei MH, Farahmand M, Ziaee A, Amini E, Ziaee M.

J Med Virol. 2019 Mar 25. doi: 10.1002/jmv.25470. [Epub ahead of print]

PMID:
30908666
2.

Ceftriaxone-associated nephrolithiasis and gallstone in adults.

Azarkar G, Birjand MM, Ehsanbakhsh A, Bijari B, Abedini MR, Ziaee M.

Drug Healthc Patient Saf. 2018 Dec 12;10:103-108. doi: 10.2147/DHPS.S183892. eCollection 2018.

3.

Facile green synthesis of silver nanoparticles using Berberis vulgaris leaf and root aqueous extract and its antibacterial activity.

Behravan M, Hossein Panahi A, Naghizadeh A, Ziaee M, Mahdavi R, Mirzapour A.

Int J Biol Macromol. 2019 Mar 1;124:148-154. doi: 10.1016/j.ijbiomac.2018.11.101. Epub 2018 Nov 14.

4.

Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.

Azarkar Z, Ziaee M, Ebrahimzadeh A, Sharifzadeh G, Javanmard D.

J Med Virol. 2019 Apr;91(4):615-622. doi: 10.1002/jmv.25343. Epub 2018 Nov 8.

PMID:
30345529
5.

Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier.

Azarkar Z, Ebrahimzadeh A, Sharifzadeh G, Ziaee M, Fereidouni M, Taheri F.

Caspian J Intern Med. 2018 Spring;9(2):184-188. doi: 10.22088/cjim.9.2.184.

6.

Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran.

Kazemi T, Hajihosseini M, Moossavi M, Hemmati M, Ziaee M.

Clin Med Insights Cardiol. 2018 Feb 20;12:1179546818759286. doi: 10.1177/1179546818759286. eCollection 2018.

7.

Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.

Mozhgani SH, Malekpour SA, Norouzi M, Ramezani F, Rezaee SA, Poortahmasebi V, Sadeghi M, Alavian SM, Zarei-Ghobadi M, Ghaziasadi A, Karimzadeh H, Malekzadeh R, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Jahantigh HR, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Keyvani H, Kalantari E, Fakhari Z, Geravand B, Jazayeri SM.

Arch Virol. 2018 Jun;163(6):1479-1488. doi: 10.1007/s00705-018-3764-3. Epub 2018 Feb 13.

PMID:
29442226
8.

Detection of Chlamydia trachomatis in Pap Smear Samples from South Khorasan Province of Iran.

Javanmard D, Behravan M, Ghannadkafi M, Salehabadi A, Ziaee M, Namaei MH.

Int J Fertil Steril. 2018 Apr;12(1):31-36. doi: 10.22074/ijfs.2018.5064. Epub 2017 Feb 15.

9.

Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia.

Javanmard D, Ziaee M, Ghaffari H, Namaei MH, Tavakoli A, Mollaei H, Moghoofei M, Mortazavi HS, Monavari SH.

Blood Res. 2017 Dec;52(4):311-315. doi: 10.5045/br.2017.52.4.311. Epub 2017 Dec 26.

10.

Prevalence and Determinants of Hypertension among Iranian Adults, Birjand, Iran.

Kazemi T, Hajihosseini M, Mashreghimoghadam H, Azdaki N, Ziaee M.

Int J Prev Med. 2017 May 25;8:36. doi: 10.4103/ijpvm.IJPVM_103_16. eCollection 2017.

11.

Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran.

Ziaee M, Javanmard D, Sharifzadeh G, Hasan Namaei M, Azarkar G.

Hepat Mon. 2016 Jul 25;16(10):e37806. eCollection 2016 Oct.

12.

Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran.

Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, Bijari B, Karamian M, Sharifzadeh G.

Hepat Mon. 2016 Aug 14;16(9):e36452. eCollection 2016 Sep.

13.

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline.

Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, Mohraz M, Mardani M, Fattahi MR, Poustchi H, Nikbin M, Nabavi M, Adibi P, Ziaee M, Behnava B, Rezaee-Zavareh MS, Colombo M, Massoumi H, Bizri AR, Eghtesad B, Amiri M, Namvar A, Hesamizadeh K, Malekzadeh R.

Hepat Mon. 2016 Aug 13;16(8):e40959. eCollection 2016 Aug. Review.

14.

Vaccination Against Hepatitis A for Hemophilic Patients: Is It Necessary?

Mirzaei J, Ziaee M, Farsad SA, Fereydooni M, Anani Sarab G, Rezvani Khorashad MR.

Hepat Mon. 2016 Apr 5;16(4):e37447. doi: 10.5812/hepatmon.37447. eCollection 2016 Apr.

15.

Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces.

Ramezani F, Alavian SM, Sadeghi A, Khedive A, Ghalichi L, Norouzi M, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Keyvani H, Kalantari E, Saberfiroozi M, Rezaee R, Daram M, Mahabadi M, Goodarzi Z, Poortahmasebi V, Geravand B, Khamseh A, Mahmoodi M, Jazayeri SM.

Iran J Microbiol. 2015 Aug;7(4):214-20.

16.

The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients.

Ziaee M, Namaei MH, Azarkar G.

Pak J Med Sci. 2015 Sep-Oct;31(5):1246-9. doi: 10.12669/pjms.315.7888.

17.
18.

Severe falciparum malaria in iran: a very rare case from an endemic region.

Ziaee M, Abedi F.

Jundishapur J Microbiol. 2014 Jan;7(1):e8752. doi: 10.5812/jjm.8752. Epub 2014 Jan 1.

19.
20.

Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic (East of iran) in 2012.

Ziaee M, Azarkar G.

Hepat Mon. 2013 Aug 25;13(8):e11168. doi: 10.5812/hepatmon.11168. eCollection 2013.

21.

Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients.

Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Hossein Somi M, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Ali Judaki M, Ghamari S, Daram M, Fazeli Z, Goodarzi Z, Khedive A, Moradi A, Jazayeri SM.

Hepat Mon. 2013 Jan 20;13(1):e6712. doi: 10.5812/hepatmon.6712. Print 2013 Jan.

22.

Informative STR Markers for Marfan Syndrome in Birjand, Iran.

Dadkhah E, Ziaee M, Davari MH, Kazemi T, Abbaszadegan MR.

Iran J Basic Med Sci. 2012 Sep;15(5):1020-5.

23.
24.
25.

Prevalence of primary drug resistant Mycobacterium tuberculosis in Mashhad, Iran.

Namaei MH, Sadeghian A, Naderinasab M, Ziaee M.

Indian J Med Res. 2006 Jul;124(1):77-80.

PMID:
16926460

Supplemental Content

Loading ...
Support Center